The prognosis is impaired in NAFLD patients with diabetes despite negative FIB4 <1.30

被引:0
|
作者
Boursier, Jerome [1 ]
Ekstedt, Mattias [2 ]
Gomez, Manuel Romero [3 ]
Moreau, Clemence [4 ]
Bonacci, Martin [5 ]
Cure, Sandrine [5 ]
Trylesinski, Aldo [5 ]
Hagstrom, Hannes [6 ]
机构
[1] Angers Univ Hosp, Angers, France
[2] Linkoping Univ, Linkoping, Sweden
[3] Univ Seville, Seville, Spain
[4] Angers Univ, Angers, France
[5] Intercept, London, North Ireland
[6] Karolinska Inst, Stockholm, Sweden
关键词
D O I
暂无
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
PO-313
引用
收藏
页码:S557 / S558
页数:2
相关论文
共 50 条
  • [1] NAFLD: CASE-FINDING IN DIABETIC PATIENTS FROM PRIMARY CARE USING FIB4 SCORE
    Mansour, Dina
    Cassidy, Paul
    GUT, 2018, 67 : A127 - A127
  • [2] Risk assessment and correlation of MAFLD and FIB4 index in patients with type 2 diabetes
    Polisetti, S.
    Tippisetty, S.
    Seshadri, K.
    Reddy, S. A.
    DIABETES RESEARCH AND CLINICAL PRACTICE, 2024, 209
  • [3] Ability of a Combined FIB4/miRNA181a Score to Predict Significant Liver Fibrosis in NAFLD Patients
    Lima, Rodrigo Vieira Costa
    Stefano, Jose Tadeu
    Malta, Fernanda de Mello
    Pinho, Joao Renato Rebello
    Carrilho, Flair Jose
    Arrese, Marco
    Oliveira, Claudia P.
    BIOMEDICINES, 2021, 9 (12)
  • [4] Cardiometabolic Risk Factors Superior to FIB4 in Identifying Adults at Risk for NAFLD with Fibrosis
    Leiva, Eddison Godinez
    Sharma, Anu
    Kalavalapalli, Srilaxmi
    Rocha, Andrea Ortiz
    Saenz, Enrique Valdez
    Mohseni, Yasmine
    Pardo, Nathaly Cuervo
    Rosenberg, Jens T.
    Grajo, Joseph R.
    Barb, Diana
    Cusi, Kenneth
    DIABETES, 2024, 73
  • [5] Has my liver got diabetes? Fib4 score as a screening marker for early detection of non-alcoholic fatty liver disease (NAFLD) for patients with type 2 diabetes
    Zeeshan, A.
    Powney, R.
    Housley, D.
    Khana, P.
    Sen, S.
    Wong, K.
    Soo, S.
    DIABETIC MEDICINE, 2022, 39
  • [6] Is liver stiffness measurement (LSM) by Fibroscan better than FIB4 score for prediction of clinically significant fibrosis in patients with NAFLD?
    Vuppalanchi, Raj
    Gawrieh, Samer
    Weber, Regina
    Chalasani, Naga P.
    HEPATOLOGY, 2014, 60 : 606A - 606A
  • [7] Can FIB4 and NAFLD fibrosis scores help endocrinologists refer patients with non-alcoholic fat liver disease to a hepatologist?
    Nones, Rodrigo Bremer
    Ivantes, Claudia Pontes
    Alves Pedroso, Maria Lucia
    ARCHIVES OF ENDOCRINOLOGY METABOLISM, 2017, 61 (03): : 276 - 281
  • [8] Screening for liver fibrosis in tertiary care using automatic calculation of FIB4 in patients at-risk of diabetes
    Canivet, Clemence M.
    Rolland, Celine
    Joubaud, Francoise
    Genevieve, Franck
    Gervais, Stephane
    Oberti, Frederic
    Prunier, Delphine
    Moal, Valerie
    Michalak, Sophie
    Fouchard, Isabelle
    Lannes, Adrien
    Boursier, Jerome
    JOURNAL OF HEPATOLOGY, 2024, 80 : S519 - S519
  • [9] VALIDATION OF A CLINICAL CARE PATHWAY TO RISK STRATIFY PATIENTS WITH NAFLD AND COMPARING FIB4 SCORING WITH OTHER NON- INVASIVE TESTING
    Kundu, Ria Ghose
    Rangan, Pooja
    Faulkner, Claire
    Aboona, Majd
    Grade, Dylan
    Sharma, Rahul
    Dolasa-Sahani, Vir
    Shaik, Naina
    Shaik, Rayna
    Nadeem, Rida
    Wijarnpreecha, Karn
    Alkhouri, Naim
    HEPATOLOGY, 2023, 78 : S899 - S902
  • [10] Liver Stiffness Assessed by Fib4 Index Predicts Mortality in Heart Failure Patients
    Sato, Yu
    Yoshihisa, Akiomi
    Watanabe, Shunsuke
    Yokokawa, Tetsuro
    Miura, Shunsuke
    Sato, Takamasa
    Suzuki, Satoshi
    Oikawa, Masayoshi
    Kobayashi, Atsushi
    Yamaki, Takayoshi
    Kunii, Hiroyuki
    Saitoh, Shu-ichi
    Takeishi, Yasuchika
    CIRCULATION, 2016, 134